(24/7 MARKET NEWS) – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) stated, after yesterday’s market close, that it withdrew the Form S-1 Offering Registration Statement it filed with the SEC on November 28, 2022, and amended on November 30, 2022.
TransCode is trading at $0.63, up $0.21 (+50.60%), on nearly 2 million premarket shares traded.
Its 52-week range is $ 0.3701 to $3.13. Its next inflection points are $0.70 and $0.75. if it can break through the 75-cent resistance level, with strong volume, it would be a favorable setup for a potential run to the $1 level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to ww\w.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
